Purchase Order HHSN272201301062P
Award Date
9/12/13
Potential Completion Date
9/19/13
Potential Value
$5.4K
Federal Agency
NIAID DEA OA Acquisitions
Ultimate Awardee
Not listed
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02126, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMass Medical) for the purchase of a 7 mg vial of the CD3 immunotoxin PR-0307 at a firm fixed price of $7,000.00. The award has no set-aside designation and was made as a purchase order on August 5, 2014, with a completion date of September 3, 2014. UMass Medical, which operates as a...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order to the University of Massachusetts Biologic Labs, doing business as Massbiologics, to provide 25 doses of EDAT 160,000IU. The contract has a potential value of $125,000.00 and a completion date of September 20, 2023. The University of Massachusetts is the prime contractor, and there are no set-aside designations mentioned. The CDC is the primary customer for this...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to EBioscience, Inc., a subsidiary of Affymetrix, Inc. The contract is for the supply of 500 milligrams of a CD 4 functional grade depletion antibody, with a ceiling value of $15,000.00. The contract was awarded on September 18, 2013, with an ultimate completion date of October 2, 2013. The contract was set aside for...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for the delivery of antibodies. The contract has a ceiling value of $12,270.20 and was awarded on August 6, 2015 with an ultimate completion date of August 28, 2015. The contract was not set aside for any specific business classification. BD is a global medical technology company...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The contract is for the delivery of 20 mg of the CD45 MB4-6D6 antibody product in 5 x 1 mL aliquots at a concentration of 4 mg/mL. The total ceiling value of the award is $12,851.00 with a period of performance through June 30, 2016. This contract was awarded without any set-aside designation....
This federal contract award, HHSN272201600011C, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to the University of Massachusetts Medical School (UMMS) for "STAGED VACCINE DEVELOPMENT". The $17,298,573.00 cost-no-fee contract does not have a set-aside designation. Under this contract, UMMS serves as the prime contractor and has subcontracted a portion of the work to the University...
The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,657.20 firm fixed-price purchase order to Ebioscience, Inc., a subsidiary of Affymetrix, Inc., for the supply of monoclonal antibodies, including shipping charges. The contract, which does not have a set-aside designation, was awarded on September 11, 2011, with a completion date of September 19, 2012. This standing order is likely part of NIAID's broader efforts to...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract, worth a guaranteed minimum of $50,000.00, was awarded to the University of Massachusetts Medical School (UMass Medical) to provide animal models of infectious diseases research under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite delivery vehicle (IDV). The contract is a firm...
This federal contract award is for ANTIBODIES AND BIOLOGICALS, issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Becton, Dickinson and Company (BD). The $4,514.60 firm fixed-price purchase order does not have a set-aside designation. BD is a global medical technology company that provides a range of medical supplies, instruments, and diagnostic products, including flow cytometry and cell...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for the supply of antibodies. The contract has a ceiling value of $12,168.40 and a completion date of September 19, 2014. BD is a global medical technology company that provides a wide range of medical supplies, instruments, laboratory equipment, and diagnostic products to government agencies. The company has extensive experience as...